Stature Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth -0.63%
- Profit Growth 16.08%
- Ebitda 33.10%
- Net Worth 76.55%
- Total Assets 64.59%
About Stature Life Sciences
Stature Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 January 2017 (Eight years and one month 3 days old ). Its registered office is in Chennai City Corporation, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Lazer Jesudoss, Charles Rajendren, Vellingirisamy Rangasamy, and One other member serve as directors at the Company.
Company Details
-
Location
Chennai City Corporation, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290TN2017PTC114053
-
Company No.
114053
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Jan 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Stature Life Sciences Private Limited offer?
Stature Life Sciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API.
Who are the key members and board of directors at Stature Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemalatha Jayaraman
|
Managing Director | 06-Jan-2017 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Lazer Jesudoss
|
Additional Director | Current | |
|
Charles Rajendren
|
Director | 06-Jan-2017 | Current |
|
Vellingirisamy Rangasamy
|
Director | 05-Oct-2021 | Current |
Financial Performance of Stature Life Sciences.
Stature Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.63% decrease. The company also saw a substantial improvement in profitability, with a 16.08% increase in profit. The company's net worth Soared by an impressive increase of 76.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stature Life Sciences?
In 2023, Stature Life Sciences had a promoter holding of 78.00% and a public holding of 22.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2023 | State Bank Of India | ₹1.00 Cr | Open |
How Many Employees Work at Stature Life Sciences?
Stature Life Sciences has a workforce of 19 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stature Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stature Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
